Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Alexander Burnett

Concepts (195)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Laparoscopy
7
2024
170
2.070
 Why?
Endometrial Neoplasms
8
2024
137
1.910
 Why?
Uterine Cervical Neoplasms
12
2022
277
1.730
 Why?
Lymph Node Excision
5
2024
138
1.540
 Why?
Neoplasm Staging
8
2024
749
0.920
 Why?
Obesity, Morbid
2
2023
77
0.910
 Why?
Natural Orifice Endoscopic Surgery
1
2023
4
0.900
 Why?
Whole-Body Irradiation
2
2014
129
0.860
 Why?
Gynecologic Surgical Procedures
4
2009
28
0.860
 Why?
Sentinel Lymph Node Biopsy
1
2024
118
0.860
 Why?
Metformin
2
2020
63
0.640
 Why?
Hypoglycemic Agents
2
2020
169
0.610
 Why?
Interleukin-11
2
2013
5
0.530
 Why?
Neoplasm Recurrence, Local
3
2016
630
0.490
 Why?
2-Pyridinylmethylsulfinylbenzimidazoles
1
2014
19
0.470
 Why?
Prescription Drugs
1
2014
38
0.460
 Why?
Hysterectomy
4
2023
88
0.450
 Why?
Uterine Neoplasms
7
2007
60
0.450
 Why?
Proton Pump Inhibitors
1
2014
84
0.440
 Why?
Radiation Tolerance
1
2014
83
0.440
 Why?
Radiation-Protective Agents
1
2013
72
0.420
 Why?
Obesity
2
2016
1112
0.420
 Why?
Robotics
2
2010
41
0.410
 Why?
Female
32
2024
26829
0.390
 Why?
Organotechnetium Compounds
1
2011
6
0.380
 Why?
Lymphedema
1
2011
43
0.360
 Why?
Vulvar Neoplasms
1
2011
58
0.350
 Why?
Lower Extremity
1
2011
92
0.350
 Why?
Radiopharmaceuticals
1
2011
205
0.340
 Why?
Carcinoma, Squamous Cell
2
2011
330
0.340
 Why?
Cystadenocarcinoma, Papillary
5
2006
14
0.320
 Why?
Humans
34
2024
50201
0.300
 Why?
Adult
19
2024
13486
0.290
 Why?
Fertility
2
2009
28
0.290
 Why?
Retroperitoneal Space
2
2024
32
0.290
 Why?
Aged
16
2024
9505
0.290
 Why?
Retrospective Studies
5
2023
6190
0.290
 Why?
Middle Aged
18
2024
12356
0.280
 Why?
Vagina
2
2023
45
0.280
 Why?
Cervix Uteri
1
2006
48
0.250
 Why?
Adenocarcinoma
1
2009
402
0.250
 Why?
Topotecan
1
2005
17
0.240
 Why?
Polyethylene Glycols
1
2005
86
0.230
 Why?
Genital Neoplasms, Female
1
2004
41
0.230
 Why?
Postoperative Complications
1
2011
1027
0.230
 Why?
Ovarian Neoplasms
4
2014
450
0.220
 Why?
Feasibility Studies
2
2024
383
0.210
 Why?
Doxorubicin
1
2005
234
0.210
 Why?
Uterus
1
2023
91
0.210
 Why?
Lymph Nodes
1
2004
258
0.200
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2007
1000
0.200
 Why?
Gene Expression Regulation, Neoplastic
6
2011
824
0.200
 Why?
Aged, 80 and over
5
2016
3158
0.190
 Why?
Prospective Studies
3
2024
2396
0.170
 Why?
Intestines
2
2013
171
0.170
 Why?
Carcinoma
2
2011
139
0.150
 Why?
Cell Proliferation
2
2020
987
0.150
 Why?
Antineoplastic Agents
2
2007
1176
0.140
 Why?
Cancer Vaccines
3
2014
78
0.140
 Why?
Dendritic Cells
3
2014
133
0.140
 Why?
Kruppel-Like Transcription Factors
2
2020
35
0.140
 Why?
Cystadenocarcinoma, Serous
3
2005
71
0.130
 Why?
Enterotoxins
2
2007
12
0.130
 Why?
Aromatase Inhibitors
2
2007
14
0.130
 Why?
Pregnancy
1
2023
2609
0.130
 Why?
Nitriles
2
2007
52
0.130
 Why?
Kallikreins
2
2006
18
0.130
 Why?
Mice
4
2014
5673
0.130
 Why?
Triazoles
2
2007
112
0.120
 Why?
Receptor, erbB-2
2
2005
74
0.120
 Why?
Neoplasms
1
2005
1233
0.120
 Why?
Medical Oncology
2
2006
96
0.120
 Why?
Lethal Dose 50
1
2014
12
0.120
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2014
16
0.120
 Why?
Hematopoiesis
1
2014
71
0.110
 Why?
Hydrogen-Ion Concentration
1
2014
177
0.110
 Why?
Ascites
1
2014
29
0.110
 Why?
Safety
1
2014
77
0.110
 Why?
Survival Analysis
2
2013
670
0.110
 Why?
Stomach
1
2014
80
0.110
 Why?
Spectrometry, Fluorescence
1
2013
47
0.110
 Why?
Carcinoma, Endometrioid
2
2010
38
0.100
 Why?
Incidence
1
2016
1000
0.100
 Why?
CD4-Positive T-Lymphocytes
1
2014
157
0.100
 Why?
Administration, Oral
1
2013
432
0.100
 Why?
Papillomaviridae
3
2013
102
0.100
 Why?
Animals
5
2014
13141
0.100
 Why?
Cytokines
1
2014
607
0.090
 Why?
Arkansas
1
2016
1988
0.080
 Why?
Cerclage, Cervical
1
2009
8
0.080
 Why?
Treatment Outcome
3
2011
5203
0.080
 Why?
Estrogens
1
2011
222
0.080
 Why?
Gene Amplification
2
2005
57
0.080
 Why?
Genes, erbB-2
2
2005
8
0.080
 Why?
Male
4
2014
25572
0.080
 Why?
Carcinoma, Papillary
2
2005
49
0.070
 Why?
Membrane Proteins
2
2007
347
0.070
 Why?
Melanoma
1
2011
281
0.070
 Why?
Intestinal Diseases
1
2007
26
0.070
 Why?
Leiomyosarcoma
1
2007
23
0.070
 Why?
Clostridium perfringens
1
2007
6
0.070
 Why?
Carcinosarcoma
1
2007
18
0.070
 Why?
Radiation Injuries, Experimental
1
2007
82
0.070
 Why?
Endometrium
2
2020
40
0.070
 Why?
Infertility, Female
1
2006
18
0.070
 Why?
Oncogene Proteins, Viral
1
2005
52
0.060
 Why?
Fellowships and Scholarships
1
2006
118
0.060
 Why?
Dysgerminoma
1
2004
3
0.060
 Why?
Medroxyprogesterone Acetate
1
2004
6
0.060
 Why?
Patient Selection
1
2006
254
0.060
 Why?
Gynecology
1
2004
49
0.060
 Why?
Immunotherapy, Adoptive
1
2005
159
0.060
 Why?
Interleukin-6
1
2005
266
0.060
 Why?
Lymphatic Metastasis
1
2004
226
0.060
 Why?
Drug Therapy, Combination
1
2005
382
0.050
 Why?
Antibodies, Monoclonal
1
2007
459
0.050
 Why?
Adolescent
4
2013
6459
0.050
 Why?
Immunohistochemistry
4
2007
973
0.050
 Why?
Immunotherapy
1
2005
235
0.050
 Why?
DNA-Binding Proteins
1
2005
424
0.050
 Why?
Cells, Cultured
3
2014
1587
0.050
 Why?
Education, Medical, Graduate
1
2004
213
0.050
 Why?
Lung Neoplasms
1
2007
601
0.050
 Why?
Gene Expression Profiling
1
2005
1029
0.040
 Why?
Preoperative Period
1
2020
47
0.040
 Why?
PTEN Phosphohydrolase
1
2020
53
0.040
 Why?
Receptors, Progesterone
1
2020
63
0.040
 Why?
Estrogen Receptor alpha
1
2020
86
0.040
 Why?
Cell Line, Tumor
3
2007
1390
0.040
 Why?
Pilot Projects
1
2020
703
0.040
 Why?
Claudin-3
2
2007
5
0.030
 Why?
Claudin-4
2
2007
7
0.030
 Why?
Mice, SCID
2
2007
173
0.030
 Why?
Lymphocyte Activation
2
2007
171
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
2
2006
234
0.030
 Why?
In Situ Hybridization, Fluorescence
2
2005
256
0.030
 Why?
Apoptosis
1
2020
1093
0.030
 Why?
Coculture Techniques
1
2014
143
0.030
 Why?
p38 Mitogen-Activated Protein Kinases
1
2014
96
0.030
 Why?
Human Umbilical Vein Endothelial Cells
1
2014
90
0.030
 Why?
Combined Modality Therapy
2
2007
639
0.030
 Why?
Optics and Photonics
1
2013
11
0.030
 Why?
Antigens, Neoplasm
1
2014
146
0.030
 Why?
Drug Resistance, Neoplasm
2
2005
315
0.030
 Why?
Spectrum Analysis
1
2013
71
0.030
 Why?
Uterine Cervical Dysplasia
1
2013
49
0.030
 Why?
RNA, Messenger
2
2005
1097
0.020
 Why?
Early Detection of Cancer
1
2013
164
0.020
 Why?
Gene Silencing
1
2011
114
0.020
 Why?
Papillomavirus Infections
1
2013
167
0.020
 Why?
Prognosis
2
2005
1963
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2007
12
0.020
 Why?
Neoplasm Transplantation
1
2007
84
0.020
 Why?
Mast Cells
1
2007
54
0.020
 Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
 Why?
Remission Induction
1
2007
206
0.020
 Why?
Transforming Growth Factor beta
1
2007
136
0.020
 Why?
Lymphocytes
1
2007
154
0.020
 Why?
Intestinal Mucosa
1
2007
217
0.020
 Why?
Recombinant Proteins
1
2007
480
0.020
 Why?
Hypersensitivity, Delayed
1
2005
19
0.020
 Why?
Papillomavirus E7 Proteins
1
2005
31
0.020
 Why?
Sampling Studies
1
2005
37
0.020
 Why?
Antigens, Viral
1
2005
43
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2007
224
0.020
 Why?
Probability
1
2005
164
0.020
 Why?
Injections, Intraperitoneal
1
2005
57
0.020
 Why?
Paraffin Embedding
1
2005
52
0.020
 Why?
Statistics, Nonparametric
1
2005
193
0.020
 Why?
Biopsy, Needle
1
2005
182
0.020
 Why?
Carboplatin
1
2004
51
0.010
 Why?
Etoposide
1
2004
71
0.010
 Why?
Xenograft Model Antitumor Assays
1
2005
212
0.010
 Why?
B-Lymphocytes
1
2005
175
0.010
 Why?
Flow Cytometry
1
2007
475
0.010
 Why?
Chemotherapy, Adjuvant
1
2004
121
0.010
 Why?
Receptors, Cell Surface
1
2005
120
0.010
 Why?
Tumor Cells, Cultured
1
2005
462
0.010
 Why?
Polymerase Chain Reaction
1
2005
456
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
579
0.010
 Why?
Proportional Hazards Models
1
2005
408
0.010
 Why?
Rats, Sprague-Dawley
1
2007
1581
0.010
 Why?
Oligonucleotide Array Sequence Analysis
1
2005
409
0.010
 Why?
Young Adult
1
2013
4052
0.010
 Why?
T-Lymphocytes
1
2005
329
0.010
 Why?
Clinical Competence
1
2006
397
0.010
 Why?
Sensitivity and Specificity
1
2005
871
0.010
 Why?
Case-Control Studies
1
2006
1145
0.010
 Why?
Survival Rate
1
2005
906
0.010
 Why?
Disease-Free Survival
1
2003
450
0.010
 Why?
Regression Analysis
1
2003
395
0.010
 Why?
Age Factors
1
2005
1096
0.010
 Why?
Rats
1
2007
3277
0.010
 Why?
Risk Assessment
1
2005
1255
0.010
 Why?
Child
1
2004
6862
0.010
 Why?
Burnett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (195) concept(s)
_
Co-Authors Expand Description
See all (5) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department